Aspirin resistance in secondary stroke prevention

Acta Neurologica Scandinavica

Volumn 113, Issue 1, 2006, Pages 31-35

  Berrouschot, J ^a,c   Schwetlick, B ^a   Von Twickel, G ^b   Fischer, C ^a   Uhlemann, H ^a   Siegemund, T ^b   Siegemund, A ^b   Roessler, A ^b  

^a Municipal Hospital Altenburg   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c KKH Altenburg ^*  (Germany)

Author keywords

Aspirin; Aspirin resistance; Ischemic stroke; Stroke prevention

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PHENPROCOUMON;

ADULT; AGE; AGED; ARTICLE; BLOOD CLOTTING PARAMETERS; CANCER; DRUG HYPERSENSITIVITY; DUODENUM ULCER; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GENDER; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREATITIS; PROSPECTIVE STUDY; RASH; RISK FACTOR; STOMACH PAIN; STOMACH ULCER; STROKE; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; TREATMENT OUTCOME;

AGED; ASPIRIN; CEREBROVASCULAR ACCIDENT; DRUG RESISTANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; RECURRENCE;

EID: 33645243032     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2005.00419.x     Document Type: Article

References (30)

1. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients Br Med J 2002 524 71 86
2. G rotemeyer KH. Effects of acetylsalicylic acid in stroke patients. Evidence of Nonresponders in a subpopulation of treated patients Thromb Res 1991 63 587 93
3. H elgason CM B olin KM H off JA et al. Development of aspirin resistance in persons with previous ischemic stroke Stroke 1994 25 2331 6
4. G rundmann K J aschonek K K leine B D ichgans J T opka H. Aspirin non-responder status in patients with recurrent cerebral ischemic attacks J Neurol 2003 250 63 6
5. A lberts MJ B ergman DL M olner E J ovanovic BD U shiwata I T eruya J. Antiplatelet effect of aspirin in patients with cerebrovascular disease Stroke 2004 35 175 8
6. G rotemeyer KH S charafinski HW H usstedt IW. Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients Thromb Res 1993 71 397 403
7. A dams HP B enedixen BH K appelle LJ et al. TOAST Investigators. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial Stroke 1993 24 35 41
8. B orn GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal Nature 1962 194 927 9
9. F ujimura A C hashi K E bihara A. Daily variations in platelet aggregation and adhesion in healthy subjects Life Sci 1992 50 1043 7
10. G um PA K ottke -M archant K P oggio ED et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease Am J Cardiol 2001 88 230 5
11. S chrör K. Aspirin and platelets: the antiplatelet action of aspirin and it's role in thrombosis treatment and prophylaxis Semin Thromb Haemost 1997 23 349 56
12. K atzer MAA B orn GVR. Simulation of primary haemostasis in vitro Haemostasis 1985 15 357 62
13. S chwarz UR G eiger J W alter U E igenthaler M. Flow cytometry analysis of activating and inhibitory signal transduction pathways in human platelets - definition and detection of ticlopidine/clopidigrel effects Thromb Haemost 1999 82 1145 52
14. B ornschein NM K arpov VG A ronovich BD. Failure of aspirin treatment after stroke Stroke 1994 25 275
15. S yrbe G R edlich H W eidlich B et al. Individual dosing of ASA prophylaxis by controlling platelet aggregation Clin Appl Thromb Hemost 2001 7 209 13
16. P eters AJ B orries M G radaus F J ax TW S choebel FC S trauer BE. In vitro bleeding test with PFA-100 - aspects of controlling individual acetylsalicylic acid induced platelet inhibition in patients with cardiovascular disease J Thromb Thrombolysis 2001 12 263 72
17. A ndersen K H urlen M A rnesen H S eljeflot I. Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease Thromb Res 2002 1,108 37 42
18. Z immermann N K ienzle P W eber AA et al. Aspirin resistance after coronary artery bypass grafting J Thorac Cardiovasc Surg 2001 121 982 4
19. B enedek IH J oshi AS P ieniaszek HJ K ing SY K ornhauser DM. Variability in the pharmacokinetics and pharmacodynamics of low dose aspirin in healthy male volunteers J Clin Pharmacol 1995 35 1181 6
20. K omiya T K uda M U rabe T M izuno Y. Compliance with antiplatelet therapy in patients with ischemic cerebrovascular disease. Assessment by platelet aggregation testing Stroke 1994 25 2337 42
21. H elgason CM T ortorice KL W inkler SR et al. Aspirin response and failure in cerebral infarction Stroke 1993 24 345 50
22. T schoepe D R oesen P S chwippert B G ries FA. Platelets in diabetes: the role in the hemostatic regulation in atherosclerosis Semin Thromb Hemost 1993 19 122 8
23. D e L a C ruz JP A rrebola MM V illalobos MA et al. Influence of glucose concentration on the effects of aspirin, ticlopidine and clopidogrel on platelet function and platelet-subendothelium interaction Eur J Pharmacol 2004 484 19 27
24. L ee TK C hen YC K uo TL. Comparison of the effect of acetylsalicylic acid on platelet function in male and female patients with ischemic stroke Thromb Res 1987 47 295 304
25. K awasaki T O zeki Y I gawa T K ambayashi J. Increased platelet sensitivity to collagen in individuals resistant to low-dose aspirin Stroke 2000 31 591 5
26. P atrignani P S cialli MG M anarini S S antini G C erletti C E vangelista V. COX-2 is not involved in thromboxan biosynthesis by activated human platelets J Physiol Pharmacol 1999 50 661 7
27. G um P K ottke -M archant K W elsh P W hite J T opol E. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular diseases J Am Coll Cardiol 2003 41 961 5
28. B uchanan MR S chwarts L B ourass M B rister SJ P eniston CM. BRAT Investigators. Results of the BRAT study - a pilot study investigating the possible significance of ASA nonresponsiveness on the benefits and risks of ASA on thrombosis in patients undergoing coronary artery bypass surgery Can J Cardiol 2000 16 1385 90
29. CAPRIE Steering Committee A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE) Lancet 1996 348 1329 39
30. H ankey GJ E ikelboom JW. Aspirin resistance Br Med J 2004 328 477 9